Tetrabarbital

Tetrabarbital

SCHEMBL1643533

CCCC(CC)C1(CC)C(=O)NC(=O)NC1=O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.65
KDM4E B2RXH2 1/20 0.65
ALDH1A1 P00352 1/20 0.65
GABRB3 P28472 1/20 0.65
OPRD1 P41143 1/20 0.65
GABRA2 P47869 1/20 0.65
GABRB2 P47870 1/20 0.65
MMP9 P14780 2/20 0.47
LMNA P02545 4/20 0.47
POLB P06746 1/20 0.37
PKM P14618 1/20 0.37
RECQL P46063 1/20 0.33
TP53 P04637 1/20 0.32
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31
NR1I2 O75469 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabarbital SCHEMBL1643537 1.00 CYP3A4 (0.65) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Thiotetrabarbital SCHEMBL2109488 0.85 LMNA (0.67) CYP3A4KDM4EALDH1A1GABRB3OPRD1
SCHEMBL5821663 0.85 CYP3A4 (0.61) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL735353 0.78 CYP3A4 (1.00) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL2376470 0.78 CYP3A4 (1.00) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL24966 0.78 CYP3A4 (1.00) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL1256614 0.77 CYP3A4 (0.96) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL26056 0.77 CYP3A4 (0.96) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL3245534 0.77 CYP3A4 (0.96) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL3695587 0.77 CYP3A4 (0.96) CYP3A4KDM4EALDH1A1GABRB3OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9770514-B2 Tamper-resistant pharmaceutical dosage forms ExxPharma Therapeutics LLC (US) 2017-09-26 US claimed
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
US-20150064250-A1 Tamper-Resistant Pharmaceutical Dosage Forms ExxPharma Therapeutics LLC (US) 2015-03-05 US claimed
US-20130275462-A1 FILE CREATING METHOD FOR SEARCHING OF DATA, SEARCHING METHOD OF DATA FILE AND MANAGING SYSTEM FOR SEARCHING OF DATA FILE JUNG JONG SUN (KR) 2013-10-17 US claimed
US-20110246505-A1 FILE GENERATION AND SEARCH METHODS FOR DATA SEARCH, AND DATABASE MANAGEMENT SYSTEM FOR DATA FILE SEARCH SYNTEKABIO, INC. (KR) 2011-10-06 US claimed
US-20100226943-A1 SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL UNIVERSITY OF FLORIDA (US) 2010-09-09 US claimed
EP-1954244-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY Scidose, Llc (US) 2008-08-13 EP claimed
WO-2007061529-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY SCIDOSE LLC. (US) 2007-05-31 WO claimed
US-20070116729-A1 Lyophilization process and products obtained thereby SCIDOSE LLC 2007-05-24 US claimed
WO-2002006826-B1 SINGLE-PATIENT DRUG TRIALS USED WITH ACCUMULATED DATABASE OPT E SCRIP INC (US) 2002-04-04 WO claimed
US-20020032581-A1 Single-patient drug trials used with accumulated database: risk of habituation OPT-E-SCRIP, INC. 2002-03-14 US claimed
WO-2002006826-A1 SINGLE-PATIENT DRUG TRIALS USED WITH ACCUMULATED DATABASE OPT-E-SCRIP, INC. (US) 2002-01-24 WO claimed
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN claimed
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 EP claimed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 WO claimed
EP-4676535-A1 MULTI-ALBUMIN BINDING COMPOUNDS Ascendis Pharma A/S (DK) 2026-01-14 EP disclosed
EP-4676537-A1 COMPOUNDS OF DRUGS WITH AN ALBUMIN BINDING MOIETY Ascendis Pharma A/S (DK) 2026-01-14 EP disclosed
WO-1996040084-A1 COMPOSITIONS AND METHODS FOR USE OF PRESSURE SENSITIVE ADHESIVE TRANSDERMAL DEVICES CONTAINING A BIOADHESIVE HUMECTANT NOVEN PHARMACEUTICALS, INC. (US) 1996-12-19 WO disclosed
US-5446070-A Flexible, finite, bioadhesive, therapeutical agent in solid form NOVER PHARMACEUTICALS, INC. (US) 1995-08-29 US disclosed
US-5002845-A Electrophotographic image forming member and method and apparatus for transferring electrophotographic images formed on the member SEIKO EPSON CORPORATION (JP) 1991-03-26 US disclosed